Abstract:Objectives Prenatal myelomeningocele (MMC) repair is performed to decrease risk for treatment of hydrocephalus after birth and to preserve motor function. Some centers may not consider patients candidates for surgery if severe ventriculomegaly is present and there is no expected benefit in decreased risk for hydrocephalus treatment. This study sought to compare postnatal outcomes of fetuses with MMC and severe ventriculomegaly (>15mm) who underwent prenatal repair, with fetuses with severe ventriculomegaly who underwent postnatal repair and fetuses with ventriculomegaly (<15mm) who underwent prenatal repair. Methods This was a retrospective study of fetuses with MMC that underwent prenatal or postnatal repair between 2012 and 2021 at a single institution. The cohort was divided based on preoperative fetal ventricular size into two groups, those with severe ventriculomegaly (≥15 mm) and those without severe ventriculomegaly ( 0.05 was considered statistically significant. Multivariate regression analysis was used to adjust for potential confounders. Results 154 patients were included in this study: 145 patients underwent fetal surgery (101 fetoscopic and 44 open hysterotomy) and 9 patients with severe ventriculomegaly underwent postnatal repair. Among the 145 patients who underwent fetal surgery, 22 presented with severe ventriculomegaly. Prenatally repaired fetuses with severe ventriculomegaly at referral were at a significantly higher need for hydrocephalus treatment by 12 months than those without severe ventriculomegaly (62% vs. 29%, p<0.01). However, motor function assessment at birth was similar between both prenatally repaired groups (OR=0.92, 95% CI [0.33‐2.59], p=0.88) adjusted for the anatomical level of the lesion. The prenatally repaired group with severe ventriculomegaly had better preserved motor function levels at birth compared to the postnatal repair group with severe ventriculomegaly (L3 with 11.1% S1 motor function; p=<0.01 and p=<0.01). Prenatally repaired patients with severe ventriculomegaly had an 18.9 times chance of having an intact motor function at birth [95% CI (1.2 ‐ 290.1)] adjusted for ethnicity, presence of clubfeet at referral, and gestational age at delivery compared to postnatal repair. There was not a significant difference in the need for hydrocephalus treatment in the first year of life between prenatal and postnatal repair of patients with severe ventriculomegaly (61.9% vs 87.5%, p=0.18). Conclusions Although fetuses with MMC and severe ventriculomegaly do not seem to benefit from fetal surgery in terms of postnatal hydrocephalus treatment, they benefit from increased chance of preserved motor function at birth. Results from this study highlight the benefits of having prenatal MMC repair for cases with severe ventriculomegaly at referral to preserve motor function. This article is protected by copyright. All rights reserved.

Is there a role in the central nervous system development for using corticosteroids to treat meningomyelocele and hydrocephalus?

[Congenital anomalies of the central nervous system--from the pediatric standpoint].

Regression of microcephaly as a protective factor of neuropsychomotor development in fetal surgery for occipital encephalocele

[Orthopaedic Treatment for Patients with Myelomeningocele]

Neurosurgical management of Myelomeningocele in premature infants: a case series

Hydrocephalus: historical analysis and considerations for treatment

Update on the treatment of spinal cord injury

Arnold–Chiari Malformations in Pediatric Patients After Fetal Surgery for Meningomyelocele

Management and outcomes of myelomeningocele-associated hydrocephalus in low-income and middle-income countries: a systematic review and meta-analysis protocol

Prophylactic hydrocortisone in extremely preterm infants and brain MRI abnormality

Preterm lung and brain responses to mechanical ventilation and corticosteroids

Prenatal surgery in fetal myelomeningocele with severe ventriculomegaly

Association between social determinants of health and select neurosurgical procedures in the National Spina Bifida Patient Registry

Mesenchymal stem/stromal cells-a key mediator for regeneration after perinatal morbidity?

Prophylactic low-dose hydrocortisone in neonates born extremely preterm: current knowledge and future challenges

Role of neuroserpin and N-Cadherin in mesenchymal stromal cell modulation of preterm brain injury

Preventing Brain Injury in the Preterm Infant—Current Controversies and Potential Therapies

Treatment of an anterior cervicothoracic myelomeningocele together with spine deformity correction in a child: illustrative case

Effects of Antenatal Steroids with Magnesium Sulphate on Intraventricular Hemorrhage and Periventricular Leukomalacia in Neonates Born below 32 Weeks of Gestation

MRI analysis of neurodevelopmental anatomy in myelomeningocele: prenatal vs postnatal repair

The clinical significance of lack of hindbrain herniation in fetal myelomeningocele/myeloschisis patients